Navigation Links
China Medicine Releases White Paper on Developing Recombinant Aflatoxin-Detoxifizyme
Date:7/9/2008

GUANGZHOU, China, July 9 /Xinhua-PRNewswire/ -- China Medicine Corporation (OTC Bulletin Board: CHME; " China Medicine" or " the Company"), a leading distributor and developer of ethical and over-the-counter drugs, traditional Chinese Medicine (TCM), nutritional and dietary supplements, medical devices, and medical formulations in the People's Republic of China (PRC), announced today that it released a white paper on Recombinant Aflatoxin-Detoxifizyme ("rADTZ"). The paper describes the origin, development and history of rADTZ, its scientific basis, and its market potential in the feed, food and health care industries. The white paper is available for download on the Company's website: http://www.chinamedicinecorp.com/adtz.htm .

"We are very excited about the development of rADTZ, which has the potential to detoxify aflatoxin (AFT) in food and feed, and we are currently carrying out experiments on animal feed," said Mr. Senshan Yang, Chairman and CEO of China Medicine Corporation. "We hope to bring you positive news on the results in the near future."

About China Medicine Corporation

China Medicine Corporation is a leading pharmaceutical company which discovers and develops medical formulations and distributes over 2,200 pharmaceutical products in China including prescription and over-the-counter drugs, traditional Chinese medicine products, herbs and dietary supplements. The Company distributes the products to wholesale distributors in 28 provinces and to more than 300 hospitals, 500 medicine companies, and 1,788 drug stores throughout China. The Company actively develops a number of proprietary products for many uses including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company's website at http://www.chinamedicinecorp.com .

Caution
'/>"/>

SOURCE China Medicine Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Chindex International, Inc. Announces Receipt of Key Regulatory ApprovalsChina SFDA Certificates Received Include Intuitive Surgical daVinci S
2. China Improves Safety Management on Imported Foods in Preparation for Olympic Games
3. AMDL Signs Letter of Intent to Purchase China-Based Pharmaceutical Distribution Company
4. Cynosure Expands Presence in China with the Opening of Sales Office in Beijing
5. Golden Meditech Pioneers into Chinas Hospital Market
6. Chinas Leading Healthcare Market Player Records 200% Increase in Profits and Earnings
7. Thomson Reuters Introduces a New Solution to Boost Competitive Advantage in Chinas Generics and API Market
8. China Medicine Maintains Exclusive Rights to Distribute 2,300 Pharmaceutical Products
9. China Sky One Medical, Inc. Research Center Recognized by Heilongjiang Science and Technology Institute
10. China Yingxia International, Inc. Appoints Chief Financial Officer
11. China Sky One Medical, Inc. to Acquire Peng Lai Jin Chuang Company

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...s may reduce future disease burden, researchers sa...- Encouraging city dwellers to walk and bicycle in...c health benefits than increased used of low-emiss...e study compared the projected health effects in 2...for London, England, and Delhi, India: business-a...
(Date:11/27/2009)...urers who use medical load cells at the heart of t...inging in technology partner Flintec early in the ...edical manufacturers are calling in Flintec load c..., ensuring that progress will not be constrained b...d technology. , (PRWEB) N...
(Date:11/26/2009)...date (TM) has been shown in studies to be effectiv...used by an overload of copper, and certain metasta...ver, is known about how the drug works at the mole...niversity researchers now has provided an invaluab...nd to copper-loaded metallochaperones. The drug se...
(Date:11/26/2009)...ental (RTDental), a leading dental group practice ...ansion of its services to include LUMINEERS by a c... , Durham, NC (PRWEB) -- R...t Dr. Doug Macmillan, an experienced LUMINEERS D...training seminar. RTDental’s ability to ful...
(Date:11/25/2009)...Newswire-FirstCall/ -- Onyx Pharmaceuticals, Inc...y will host two investor events in December: ,,... a.m. CT/10:00 a.m. ET ,, Principal investiga...arfilzomib in relapsed and/or refractory multiple ...of Hematology (ASH) Annual Meeting and Exposition ...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...Omnicell,Inc. (Nasdaq: OMCL ), a leading provider...s, announced today that it has completed its $40.0...n Stock. A total of,2,133,898 shares were repurcha...g patient safety and operational efficiency in,hea...
...ll Changes Can Have a Big Effect on ..., N.J., March 12 Chef, nutritionist,and cookbook ...ncouraging,people with type 2 diabetes to recogniz... & Co., Inc., Chef LaLa will be,visiting selected ...
..."Superheroes" Theme, WASHINGTON, March 12 The U.... for Healthcare Research and Quality,(AHRQ) joined...anish-language national public service campaign de...ing their doctor for,regular screenings., Hispani...
...Guidance, SUNNYVALE, Calif., March 12 Cepheid (N...website, http://www.cepheid.com, ,comments on a s...ican,Medical Association regarding MRSA screening ...lion and net income,excluding stock compensation e...
...armaceuticals, a division of Wyeth (NYSE: WYE ), ...tional clinical studies to address questions from,... (CHMP) regarding the,risk-benefit profile of desv...venlafaxine for the treatment of,vasomotor symptom...
... March 11,more than 300 individuals with lupus, th...rs of Congress to increase government funding for,...will greatly expand,federal efforts on lupus. The ... lawmakers to increase funding for biomedical rese...
Other Medicine News:Health News:Omnicell Announces Completion of Its Common Stock Repurchase Plan 2Health News:Chef LaLa to Provide Healthy Menu Makeovers 2Health News:Chef LaLa to Provide Healthy Menu Makeovers 3Health News:Chef LaLa to Provide Healthy Menu Makeovers 4Health News:Chef LaLa to Provide Healthy Menu Makeovers 5Health News:AHRQ and Ad Council Encourage Hispanics to Become More Involved in Their Health Care 2Health News:AHRQ and Ad Council Encourage Hispanics to Become More Involved in Their Health Care 3Health News:AHRQ and Ad Council Encourage Hispanics to Become More Involved in Their Health Care 4Health News:Cepheid Comments on Study Regarding MRSA Surveillance Reported in the Journal of the American Medical Association 2Health News:Cepheid Comments on Study Regarding MRSA Surveillance Reported in the Journal of the American Medical Association 3Health News:More Clinical Data Required to Support European Approval of Desvenlafaxine as a Potential Treatment for Vasomotor Symptoms 2Health News:More Clinical Data Required to Support European Approval of Desvenlafaxine as a Potential Treatment for Vasomotor Symptoms 3Health News:Lupus Advocates Urge Increased Funding for Lupus Research and Education 2
(Date:11/27/2009)..., Nov. 27 ACUO TECHNOLOGIES, devel... software, data migration tools and services, is p...nd Trademark Office has approved a patent applicat...mputer Network." Acuo Technologies is pleased to a...l property. In general, the granted patent applica...
(Date:11/25/2009)...o., Nov. 25 Heska Corpor...advanced diagnostic and specialty products to the ...th Roche Diagnostics Corporation for the supply of... the veterinary market. ,, (Logo: http://w..., "Heska and Roche share the same passion for i...
(Date:11/25/2009).... 25 BioTrends Research Group, Inc...telara report, the first in a multi-phase syndic...f Centocor Ortho-Biotech,s Stelara, from product l.... Each wave of the report provides quantitative i...tative information from a subset of 20. The repor...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Healthcare and Abortion 3A Randall Terry Leads Protests and Press Conferences in 10 Cities in Five States 54976 1Healthcare and Abortion 3A Randall Terry Leads Protests and Press Conferences in 10 Cities in Five States 54976 2American Red Cross Provides Safety Tips for Rip Tides Caused by Hurricane Bill 54972 1American Red Cross Provides Safety Tips for Rip Tides Caused by Hurricane Bill 54972 2ESC Congress 2009 media alert 54968 1ESC Congress 2009 media alert 54968 2
...ytic product, WOBURN, Mass., April 22 BioVex Inc...e treatments for cancer and the prevention,of infe... and Drug,Administration (FDA) has approved the de...l evaluating its lead product, OncoVEX(GM-CSF) in,...ma. The agreement was,made under the Special Proto...
...tional Institutes of Health Small, Business Inno...2 Trial, HOUSTON, April 22 Agennix, Inc. announc...e-blind, placebo-controlled Phase 2 study,of oral ... This is the,first clinical trial of talactoferrin...ction of talactoferrin, and promising preclinical ...
Other Medicine Technology:BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO 2BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO 3Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis 2Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis 3Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis 4Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis 5
Universal Wrist/Forearm Splint
...ist is a custom wrist orthotic designed to limit t...s maximum range-of-motion. , ,Indications: , Wri...-triangular fibrocartilage complex , Coles fract...ial tendon rupture , ORIF - Open reduction and i...
Contoured Wrist/Forearm
Westport Lacing Wrist Brace
Medicine Products: